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 Novel protocol for home-based psychiatrist video-visits for perinatal depression. 
 Positive experiences among users, including comfort with communication and 
convenience. 
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Objectives: Barriers to in-person mental health care are common in pregnant and postpartum 
women with depression. We assessed the feasibility of a trial protocol for evaluating the use of 
secure, in-home synchronous virtual psychiatric care. 
 
Methods: In this pilot randomized controlled trial in Toronto, Canada, women aged >18 years, 
pregnant or 0-12 months postpartum, with Edinburgh Postnatal Depression Scale (EPDS) 
scores  >12, were randomized 1:1 to in-person visits only, or to an intervention condition where 
they were offered the option of video-visits for some or all of their follow-up care. We assessed 
trial protocol feasibility, and secondarily EPDS score at 12 weeks post-randomization. 
 
Results: 63 women were randomized (33 intervention, 30 control) of which 87.9% (n=29) in the 
intervention group and 66.7% (n=20) in control group completed the 12-week follow-up 
questionnaire. About 48.5% (n=16) of intervention group participants used video-visits at least 
once, with high acceptability for participants and providers across a number of domains, and no 
adverse events. EPDS mean scores decreased from 16.6(SD 5.06) to 11.6(SD 4.77) and 16.9(SD 
3.15) to 12.4(SD 3.96) for intervention and control groups, respectively (adjusted mean 
difference -0.64, 95%CI -2.95 to 1.67).  
 
Conclusion: It was feasible to recruit for a protocol evaluating psychiatrist video-visits for 
perinatal depression. Video-visits were acceptable to users and the psychiatrists providing their 
healthcare. A future non-inferiority efficacy trial can assess treatment outcome moderators to 
explore variability in effectiveness by illness severity and other factors, and cost-effectiveness of 
various types of video-visit strategies for psychiatric care in this population.  
 




Depression affects about 13% of women during pregnancy and postpartum (Vigod et al 
2016; Stewart and Vigod, 2016). Untreated perinatal depression has been linked to problems 
with fetal development, parent-infant attachment, and child emotional and behavioural 
development (Stein et al. 2014) and can lead to chronic maternal depression, a leading cause of 
disability worldwide (Whiteford et al., 2013). Psychological therapies can successfully treat 
depression of mild and moderate severity and medications such as antidepressants are effective 
for more severe illness (Stewart and Vigod, 2016; Vigod et al., 2016), only 20% of affected 
pregnant and postpartum women access the care needed for remission (Byatt et al., 2015).  
Individual and system-level barriers may contribute to the low treatment rates. Some 
women report stigma, shame and discomfort associated with mental health service use itself 
(Dennis and Chung-Lee, 2006). In pregnancy, barriers such as fatigue and work conflicts 
(particularly right before parental-leave) limit treatment uptake (Dennis and Chung-Lee, 2006). 
In the early postpartum - the highest risk period for mental illness perinatally - it can be 
physically difficult to attend appointments in-person. For example, women who have had 
caesarean sections cannot drive or lift objects such as infant car seats for 4-6 weeks post-
operatively (Sedgley et al., 2012). Unpredictable infant schedules are also problematic (Dennis 
and Chung-Lee, 2006). Some women lack the resources needed to arrange travel or childcare for 
children in their care while they are attending appointments (Dennis and Chung-Lee, 2006). This 
may be especially challenging for low-income women and new immigrants, whose treatment 
rates are very low despite a high burden of illness (Sedgley et al., 2012).  
Video-visits are an attractive solution to some of the aforementioned barriers. A 
systematic review (7 studies) showed that virtual therapy for postpartum depression delivered by 
allied health professionals via video-visits was as effective as in-person care (Ashford et al., 
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2016). However, there is limited research about the use of video-visits in women with more 
severe symptoms that require physician-based diagnosis and treatment (Stewart and Vigod, 
2016; Vigod et al., 2016).  Especially prior to the rapid shift to virtual care that occurred during 
the containment efforts brought in during the global COVID-19 pandemic late in the year 2019 
and early in the year 2020, video-visits with physicians were mainly applied to increase care in 
rural and remote regions. Therein, the patient would still attend an in-person appointment 
(usually at a primary care provider’s office) to receive consultation from a specialist remotely. 
While this approach addresses the lack of regional specialist availability, it does not necessarily 
help women who struggle to attend in-person appointments due to unpredictable infant 
schedules, childcare challenges, inability to take time off work, or travel barriers.   
New means of securely providing virtual care in any setting, such as mobile personal 
device video-conferencing, are emerging (Bashshur et al., 2015). Previous research shows that 
women are receptive to receiving perinatal psychiatrist care remotely and the number of 
individuals with personal smartphones and/or computers who have the ability to access virtual 
care is rapidly increasing (Rai et al., 2016).  This study aimed to evaluate the feasibility of a trial 
protocol offering the option of secure, in-home, real time video-visits with a psychiatrist for 
pregnant and postpartum women with depressive symptomatology, to inform the design of a 
large-scale clinical trial. We evaluated the practicality of recruitment and retention procedures, 
and the acceptability of the video-visit option for participants and the psychiatrists providing 
their care. We also compared depressive symptom scores between those in the video-visit group 






Study Design and Setting 
 This was a parallel-group pilot randomized controlled trial (RCT) conducted from 
October 2017 to September 2018 in Ontario, Canada’s largest province.  Women referred to two 
specialized perinatal psychiatric clinics in the University of Toronto research hospital system in 
Toronto, Canada, were randomized 1:1 to in-person visits only (control group), or to an 
intervention condition where they were offered the option of video-visits for some or all of their 
follow-up psychiatric care (video-visit group).  The primary trial endpoint for participants was 12 
weeks post-randomization. Provider perspectives from the nine psychiatrists who provided 
psychiatric care to the patients randomized to the video-visit group were collected after 
participant data collection was complete. Based on prior research at the participating sites, it was 
estimated that a 12 month recruitment period would be sufficient to ensure the minimum of 20 
participants per arm that allows for sufficient variability in assessing acceptability of an 
intervention and feasibility of trial procedures (Hertzog, 2008). 
Participants 
Potential participants were approached for the study by clinical staff who conduct brief 
telephone assessments to triage all new clinic referrals. Interested women were directed to 
research personnel for explanation of the study, screening and consent. Women were considered 
for inclusion if they (1) were aged 18 years and older, (2) were pregnant or the primary caregiver 
of a baby aged up to 1 year, (3) had a score of > 12 on the Edinburgh Postnatal Depressive Scale 
(EPDS)(Cox, 1987), (4) had internet access in a suitably private space and a device (i.e., mobile 
phone, tablet, personal computer) with video-visit capacity (including web camera and speakers), 
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and (5) were able to complete study measures online.  Initial exclusion criteria were alcohol or 
substance use disorder in the previous 12 months, active suicidal ideation, mania or psychosis.  
All consenting participants who met the initial selection criteria were assessed in-person 
by the clinic psychiatrist assigned to their case. As per standard care, this psychiatrist conducted 
an initial psychiatric assessment, provided treatment recommendations and developed a care plan 
in collaboration with the patient. Participants for whom the psychiatrist recommended follow-up 
care, and for whom the psychiatrist felt that follow-up care could be safely delivered via video, 
were eligible to be enrolled in the trial. The latter decision was left to the psychiatrists because of 
concerns they raised in the development of the protocol about whether the severity level of the 
participant might make them feel it would be unsafe to offer virtual care for some women.  
Study procedures 
Following informed consent procedures, baseline socio-demographic, obstetrical and 
psychiatric history data were collected via online participant-report questionnaires using an 
institutionally-approved secure electronic data capture system where participants were sent a 
personalized link to enter their responses. In addition, highly trained research personnel 
administered the Mini Neuropsychiatric Interview (MINI) over the telephone to assess current 
and lifetime psychiatric diagnoses (Sheehan, 1998). Participants were then allocated to study 
groups using a computer-generated randomized allocation sequence for 1:1 randomization, 
stratified by study site, with varying block size. Neither blinding of participants nor psychiatrists 
was possible due to the nature of the intervention, but neither were informed explicitly of the 
study hypotheses.  Research personnel were not blinded to group allocation as they provided 
technological support to participants and psychiatrists, but all follow-up data were submitted 




Participants were eligible for follow-up psychiatric care from the psychiatrist who 
conducted their initial consultation visit.  Individual follow-up care is primarily provided by 
psychiatrists in the clinics, including all prescribing.  However, most evidence-based 
psychotherapy for depression in the participating clinics is delivered by highly trained masters-
prepared social work psychotherapists; virtual psychotherapy delivered by these providers has 
been evaluated separately (Yang et al., 2019).  Participants in the control group received only the 
option of in-person psychiatric follow-up clinic visits. Participants in the intervention group also 
had the option for some or all of their follow-up visits to occur by secure videoconferencing from 
their home or another secure location of their choosing. Whether a visit was to be by video or in-
person was decided collaboratively by the participant and treating psychiatrist on a visit by visit 
basis. The protocol was designed in this manner due to psychiatrist concerns about their ability to 
deliver safe and effective care to participants with a mandated video-visit only protocol, given 
the severity and complexity of the population. All follow-up visits (video and in-person) were 
pre-scheduled, with frequency as per standard clinical care.  
Video-visits were conducted using a secure platform hosted by the Ontario Telemedicine 
Network (OTN), the government-funded agency that provides video-visit services to patients 
across Ontario and allows for physician reimbursement. Connections to the OTN network (from 
both psychiatrists and participants) were made via a secure socket layer (SSL) connection. All 
traffic was AES 128 bit encrypted, a standard adapted by all major healthcare organizations to 
protect patient privacy. Women used their own devices (i.e. mobile devices, laptop or personal 
computers) and providers accessed the OTN system from their secure institutional desktops. 
Video-visits were conducted using the OTN tool, SendInvite, a secure audiovisual portal 
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compatible with PC and iOS operating systems. At the time of, or just prior to, the scheduled 
video-visit, the psychiatrist sent an electronic invitation from SendInvite directly to the 
participant’s email address. This email contained a secure, unique link to the video portal. At the 
designated appointment time, the participant opened the secure link from their invitation email 
and the visit was initiated. Visits were conducted in real time and users could share their 
computer screens for educational material or visual models.  No data from the video visits were 
recorded or archived on a server in any way, as per Ontario privacy regulations.  
Outcomes 
The primary outcome was the feasibility of the trial protocol assessed by recruitment 
rates, video-visit acceptability, and the follow-up rate for outcome data collection at 12 weeks 
post-randomization. Acceptability for participants and psychiatrists was measured using online 
questionnaires modified from prior virtual care acceptability studies that comprised both 5-point 
Likert-type scale responses and open-ended questions (Yang et al., 2019). The participant 
acceptability questionnaire was completed by those in the intervention group at 12 weeks post-
randomization; psychiatrist questionnaires were distributed after all participants reached the 12-
week endpoint.  
Secondary outcomes were participant-reported clinical outcomes at 12 weeks post-
randomization, the length of active treatment recommended by the Canadian Network for Mood 
and Anxiety Treatments (CANMAT) guidelines for major depressive disorder (Kennedy, 2016). 
Participants completed the Edinburgh Postnatal Depressive Scale (EPDS), a self-report 
depression measure validated in perinatal populations (Cox, 1987), and the State-Trait Anxiety 
Inventory (STAI), a self-report anxiety screening measure that has shown good discriminate 




We described recruitment and retention rates, and tabulated Likert scale responses from 
the participant and physician acceptability questionnaires. Comments made by participants and 
providers on the open-ended part of the acceptability questionnaires were collated. Follow-up 
mean scores on the EPDS and STAI were compared between intervention and control groups 
using analyses of covariance, where baseline score and study site were the covariates in an 
intention-to-treat analysis, with no imputation for missing data.  
The trial was registered at clinicaltrials.gov (NCT03291600). Research ethics approval 
was received at the recruiting University of Toronto academic health sciences centres: Women’s 
College Hospital (REB#2017-0061-B); Sinai Health System (17-0167-E).  
 
RESULTS 
Recruitment and Retention 
Over the 12-month study period, 112 women were assessed for eligibility, and 63 women 
were randomized (33 intervention, 30 control) (Figure 1). Several women were excluded because 
they did not attend their initial consultation visit with the psychiatrist, but none were excluded 
due to a psychiatrist’s concern about their lack of suitability for video-visits. Participants were on 
average 33.2 (SD 3.95) years of age with the majority (85.7%) married or cohabitating with a 
partner (Table 1). Almost one third (28.6%) were born outside of Canada, 22.2% had not 
completed post-secondary education and 25.4% had a family income of less than $40,000 CAD 
per year. Fewer women in the intervention group had been formally diagnosed with depression 
prior to enrollment (24.2% vs. 46.7%). Similarly, fewer were taking psychotropic medication 
(12.1% vs. 30.0%). Baseline EPDS scores in both intervention (mean 16.5, SD 4.66) and control 
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groups (mean 17.3, SD 4.17) were in the moderate to severe range. About 88.6% (n=29/33) of 
the intervention group and 64.5% (n=20/31) of controls completed the 12-week post-
randomization follow-up questionnaire. Four controls withdrew participation after randomization 
due to their allocation status; the remainder of those who did not complete the 12-week 
questionnaire were lost to follow-up.  Among those who completed at least some follow-up data, 
clinical outcome questionnaires were incomplete for 5 participants in each group. 
Participant outcomes 
No adverse events or serious adverse events were reported over the course of the trial.  
During the 12-week follow-up period, the median number of follow-up psychiatrist visits was 2 
(IQR 1-3) in the intervention group and 1 (IQR 1-2) in the control group (Wilcoxon Rank-Sum 
Test 625.5, p = 0.134).  About 66.1% of all follow-up intervention group visits were conducted 
via video, and 16 participants (48.5%) had at least one video-visit. Among video-visit users, the 
majority felt comfortable communicating with their healthcare provider via video visits (93.8%) 
and did not require assistance using the videoconferencing system (87.5%) (Table 2). Almost all 
felt they received adequate attention from their psychiatrist (93.8%) and found video visits to be 
an acceptable modality to receive health care services. All participants felt time was saved from 
travelling to their appointment and all indicated that they would use the video visits again to 
receive services. Among the 41 participants providing full baseline and outcome EPDS data, 
scores dropped from 16.6 (SD 5.06) to 11.6 (SD 4.77) in the intervention group and from 16.9 
(SD 3.15) to 12.4 (3.96) in control group at 12 weeks post-randomization, respectively (adjusted 
mean difference -0.64 (-2.95 to 1.67)(Table 3). About 60.0% in the intervention group had EPDS 
< 12 at 12-weeks post-randomization versus 61.1% of controls. Similarly, no clinically important 




All nine psychiatrists completed the provider follow-up questionnaire (Table 4). Only 
four psychiatrists felt at ease with video-visits before starting the trial, but eight reported that it 
was generally easy to learn the video technology and all indicated that it would be at least 
somewhat easy to conduct video-visits in the future. All felt that the video-visits significantly 
facilitated their patients’ treatment or recovery. In open-ended questions, psychiatrists reported 
that the greatest benefits of using virtual care in this population were its convenience, especially 
for those who lived far away and pregnant women who were on bedrest or could not miss work, 
and its impact on cost for patients (no transportation or childcare costs), which made it “patient-
centered”.  One psychiatrist commented that the video was useful to avoid last-minute 
rescheduling when a child was sick, and another commented that it provided access to care for 
women whose psychiatric symptoms were so severe that they were having difficulty leaving 
their home. While the extensive technological support by the research team was appreciated, 
problems with audio and inconsistent video were perceived as disruptive to care delivery and 
repeated technology failures due to problems with connecting led to wasted session time. 
Psychiatrists also reported difficulty integrating schedules for video-visits with the clinic 
administrative staff.  Four psychiatrists indicated that clinical factors had dissuaded them from 
providing video-visits on some occasions, due to concerns about being able to accurately assess 
and effectively treat high-acuity patients.  One commented that video was an excellent modality 
for medication management, but five psychiatrists indicated that video felt more challenging than 
in-person care for achieving a full therapeutic interaction due to difficulties interpreting non-





To our knowledge, this is the first study to evaluate the feasibility of a video-visit 
psychiatric care model for the management of perinatal depression. This pilot trial demonstrated 
the feasibility of recruiting women into a virtual care clinical trial and of operationalizing a 
video-visit protocol, with very high acceptability of video-visits among women who used them. 
Most women found the video-visit system easy to use and felt comfortable communicating with 
their psychiatrist. Several psychiatrists were initially skeptical of the video-visit protocol due to 
concerns about patient safety, and their ability to deliver high-quality care over video. Yet, no 
patients were excluded due to psychiatrist concerns about lack of suitability, despite the group as 
a whole having a relatively high initial clinical symptom load, and provider comfort and 
confidence grew over time. Clinical outcomes were reassuringly similar between the video-visit 
option and in-person only groups, and there were no adverse events, which may serve to reassure 
psychiatrists about the safety of video-visits in this population and make a video-only study arm 
of a future trial feasible.  Overall, the results suggest that proceeding to a larger non-inferiority 
trial would be feasible, with attention to implementing strategies to improve control group 
retention, maximize completeness of data collection, and ensure reliable technology for 
efficiency and effectiveness.  In a future trial, a method to account for the possibility of treatment 
moderation by transition from pregnant to postpartum status during the intervention period will 
also be important to consider. 
There were several key strengths to the pilot study protocol. We were able to recruit 
about one in every two women assessed for study eligibility, which speaks to the feasibility of 
further recruitment, in a population known to face substantial competing demands to enrollment 
in research (Frew et al., 2014). The study sample was ethnically diverse, and about one-quarter 
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were living in lower-income households, and without a college education. Further, the protocol 
was very flexible in terms of allowing for patient-provider collaborative decisions about when to 
use video, which was helpful for recruiting psychiatrist providers at the sites who had safety 
concerns about virtual care being delivered to women directly in their homes (i.e., as opposed to 
in another provider’s office).  Also, because the protocol required at least one in-person visit, 
there was no opportunity to recruit women who face the most barriers to health service use, such 
as stigma, shame, lack of access to referring providers or lack of ability to attend in-person 
appointments at all.  In a future trial, including a video-visit only arm may make the study more 
attractive to women who face these barriers, with data plans and devices made available to 
women who would otherwise not be able to connect virtually (Gordon et al., 2016). Other key 
areas for improvement relate to the low follow-up rate in the control group and the incomplete 
data submitted through the electronic data capture system, reinforcing the need for rigorous 
attention to operational protocols using the best evidence to minimise attrition in a future study 
(Brueton et al., 2014).  
The high acceptability of video-visits among participants is consistent with previous 
research in a wide range of clinical settings and samples (Shore, 2013). The clinical symptom 
results are also consistent with findings of non-inferiority in other populations (Shore, 2013). 
Only about 50% of women in the intervention group had a video-visit, however. Most 
participants were living in the local urban catchment area, so did not have long commutes to the 
study sites, and all had to come in-person at least once for their initial psychiatric assessment, 
such that this may have been a select population who did not face substantial barriers to in-
person care.  In this case, since psychiatric follow-up visits were fairly infrequent, it may be that 
a large proportion of the women simply preferred to come in-person to their appointments. This 
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aligns with research on psychotherapy video-visits delivered by trained masters of social work 
therapists where, while women found video-visits convenient, they preferred in-person 
appointments (Yang et al., 2019). Provider concerns about clinical appropriateness may have 
also contributed to non-use of video-visits in some cases, which has not been reported previously 
in virtual treatment trials for depression in pregnancy or postpartum (Loughnan et al., 2019).  It 
is possible that the acuity of participants in this study might have been greater than in prior e-
mental health perinatal treatment trials, which are mostly focused on the delivery of evidence-
based psychotherapies by non-psychiatrists (Loughnan et al., 2019). In a future trial that recruits 
women from more remote communities where in-person visits with a psychiatrist are not 
possible, engaging a woman’s local primary care or other community provider such as a public 
health nurse who could provide in-person follow-up if needed might mitigate such safety 
concerns.   
 Provider feedback highlighted key issues requiring attention. Although the women 
themselves did not seem to mind, psychiatrists found technology difficulties to be quite 
disruptive to the treatment sessions and also wasteful of time that could be spent seeing other 
patients. They found the lack of integration with their existing electronic health record to be an 
inconvenience. Processes to allow integration of video-visit technology with existing provider-
facing systems along with seamless booking of video-visits will likely optimize implementation.  
Some psychiatrists were concerned that video-visits would be inadequate for the treatment of 
women with severe symptoms.  A hybrid model is possible when women are able to attend in-
person appointments, but that may not be possible for women living in more remote settings or 
who face other barriers to in-person treatment.  Future data on treatment outcome moderators 
will help providers decide when video-visits are appropriate in their clinical populations. Further, 
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there is growing evidence video-visits may improve care coordination and provide cost-savings 
highlighting the importance to include a cost-effectiveness analysis in any future trial (Norman, 
2006). 
In summary, the results of this pilot study support the feasibility of proceeding to a large-
non-inferiority trial to evaluate video-visits in perinatal psychiatric care. Improvements in video-
visit technology making point of care use more reliable and more user-friendly are constantly 
being made.  With the ongoing containment efforts related to the global COVID19 pandemic, 
more and more institutions are focused on virtual care delivery, integrating video-visits directly 
into their electronic medical record systems, with patients able to also communicate 
asynchronously with providers and administrative staff organizing clinic schedules. A large, 
rigorously designed trial to address questions of how well virtual care works, and what works for 
whom in this population, will be timely and critical to ensuring the provision of high-quality 
psychiatric care in this complex population.   
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  Intervention (n = 33) Control (n = 30) 
Socio-Demographics Age in Years* (Mean, SD) 33.3 (2.82) 33.2 (4.82) 
Married or Cohabitating/Common-law 27 (81.8) 27 (87.1) 
Completed a University Degree 27 (81.8) 22 (73.3) 
Annual Household Income > $40,000 24 (72.7) 23 (76.7) 
Born Outside of Canada* 10 (30.3) 8 (26.7) 
Medical & Psychiatric 
History 
Pregnant 14 (42.4) 15 (50.0) 
Number of Pregnancies – Including Current (Median, IQR) 2 (1-3) 2 (1-3) 
Lifetime Diagnosis of Depression 8 (24.2) 14 (46.7) 
Lifetime Psychiatric Hospitalization 1 (3.0) 2 (6.7) 
Any Current Alcohol Use 11 (33.3) 9 (30.0) 
Any Current Smoking 2 (6.1) 1 (3.3) 
Any Current Medication for Mental Health Concerns 4 (12.1) 9 (30.0) 
Maternal Clinical 
Symptoms 
Edinburgh Postnatal Depression Scale (EPDS) Mean (SD) 16.5 (4.66) 17.3 (4.17) 
State-Trait Anxiety Inventory-State (STAI-S) Mean (SD) 51.4 (12.2) 52.5 (11.9) 




Acceptability questionnaire completed by 16 women who used video visits during the study 
Questionnaire Item % Agree or Strongly 
Agree 
Using the video technology, I can easily talk to my healthcare provider. 14 (87.5) 
Using the video technology, I can clearly hear my healthcare provider. 14 (87.5) 
My healthcare provider is able to understand my healthcare condition. 15 (93.8) 
I can see my health care provider as if we meet in person. 12 (75.0) 
I do not need assistance while using the system. 14 (87.5) 
I feel comfortable communicating with my healthcare provider. 15 (93.8) 
I think the healthcare provided by video visits is consistent. 12 (75.0) 
I obtain better access to health care services by use of video visits. 11 (68.8) 
Video visits save me time travelling to a hospital or specialist clinic. 16 (100) 
I receive adequate attention from my healthcare provider. 15 (93.8) 
Video visits provide for my health care needs. 14 (87.5) 
I find video visits an acceptable way to receive health care services. 15 (93.8) 
I would use video visits to receive health care again.1 15 (100) 
Overall, I am satisfied with the quality of service being provided via the video visits.1 13 (86.7) 





Table 3. Clinical depressive and anxiety symptom outcome data for the 29 intervention group participants 





Adjusted mean difference* 
(95% CI) 
EPDS    
  Intervention (n=24) 16.6 (5.06) 11.6 (4.77) -0.64 (-2.95 to 1.67) 
  Control (n=17) 16.9 (3.15) 12.4 (3.96)  
STAI-State    
  Intervention (n=27) 52.1 (11.9) 47.0 (13.6) 2.48 (-3.96 to 8.92) 
  Control (n=18) 53.4 (12.3) 45.4 (10.8)  
STAI-Trait    
  Intervention (n=24) 58.3 (11.2) 50.9 (11.1) 1.97 (-3.56 to 7.50) 
  Control (n=15) 58.6 (8.81) 52.2 (8.59)  





Program evaluation questionnaire completed by 9 psychiatrists who provided video visits during the study 
Questionnaire Item Mean (SD) 
How were you feeling about the use of virtual care in mental health before you 
started? 
4.13 (1.12) 
How were you feeling about the use of virtual visits in your own clinical practice 
before you started? 
3.22 (1.78) 
How were you feeling about the set-up of the virtual care technology for use in your 
practice? 
3.33 (1.11) 
How was your experience learning how to use the virtual care technology? 3.66 (1.00) 
Overall, how was your experience delivering care virtually? 4.22 (1.09) 
How do you think your patients felt about the use of virtual visits? 4.11 (0.78) 
What impact do you think virtual care services had in facilitating your patients' 
treatment/recovery? 
3.11 (1.05) 
Do you feel that virtual visits might be an option for care delivery for this patient 
population? 
3.66 (1.32) 
How are you feeling about the use of virtual care in mental health after participating 
in this study? 
4.22 (0.97) 











































Figure 1. Flowchart of participants’ progress throughout the phases of the trial  
 
 
Assessed for Eligibility (n=112) 
Excluded (n=44) 
 Not meeting inclusion criteria (n= 31) 
 Declined to consent (n=13) 
 Dropped out prior to psychiatrist confirmation 
of eligibility (n=7) 
Analysed for intention to treat (n=29/33, 87.9%) 
Incomplete responses (n=5) 
Lost to follow-up (n=4) 
 
Intervention (n= 33) 
Lost to follow-up (n=7) 
Withdrew after allocation (n=3) 
Control (n= 30) 
Analysed for intention to treat (n=20/30, 66.7%) 
Incomplete responses (n=5) 
Randomized (n=63) 
Enrollment 
Allocation 
Follow-Up 
Analysis 
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